RecruitingNot ApplicableNCT03392415

The NOrdic-Baltic Randomized Registry Study for Evaluation of PCI in Chronic Total Coronary Occlusion

The NOrdic-Baltic Randomized Registry Study for Long-term Clinical Evaluation of Adjunction of PCI to Optimal Medical Therapy in Chronic Total Coronary Occlusion


Sponsor

Leif Thuesen

Enrollment

2,000 participants

Start Date

Jun 1, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

Randomized registry for the study of CTO PCI as adjunction to optimal medical therapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial compares the outcomes of opening a fully blocked coronary artery (chronic total occlusion, or CTO) with a stent procedure versus medical treatment alone in patients with stable heart disease. You may be eligible if... - You have at least one CTO (completely blocked artery) that can be treated with a stent - You have stable coronary artery disease - You have symptoms like chest pain or shortness of breath, OR imaging shows reduced blood flow to your heart - Your blocked artery supplies a significant area of the heart You may NOT be eligible if... - Your expected survival is less than 1 year - You are on dialysis due to kidney failure - You have had non-CTO arteries treated within the past month - You have declined to give informed consent - For MRI: you have a contrast allergy, severe obesity, claustrophobia, or certain metal implants Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECTO PCI

attempted percutaneous coronary intervention of the chronic total coronary occlusion


Locations(1)

Aalborg University Hospital

Aalborg, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03392415


Related Trials